Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma

Molecular and Cellular Biochemistry

Volumn 405, Issue 1-2, 2015, Pages 97-104

  Wang, Ru ^a   Fang, Jugao ^a,b   Ma, Hongzhi ^a   Feng, Lin ^a   Lian, Meng ^a   Yang, Fan ^a   Wang, Haizhou ^a   Wang, Qi ^a,b   Chen, Xiaohong ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cell cycle; Cell proliferation; Hsa mir 203; Hypopharyngeal neoplasm

Indexed keywords

MICRORNA; MICRORNA 203; UNCLASSIFIED DRUG; MIRN203 MICRORNA, HUMAN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; COLONY FORMING CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; HYPOPHARYNX SQUAMOUS CELL CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; UPREGULATION; CELL CYCLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; HYPOPHARYNX TUMOR; ONCOGENE; PROCEDURES; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MICRORNAS; ONCOGENES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84929947013     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2401-7     Document Type: Article

References (33)

1. Davies L, Welch HG (2006) Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135:451–457
2. Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W, Menck HR, Hoffman HT (2003) National cancer data base report on osteosarcoma of the head and neck. Cancer 98:1670–1680
3. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM (1997) Hypopharyngeal cancer patient care evaluation. Laryngoscope 107:1005–1017
4. Bova R, Goh R, Poulson M, Coman WB (2005) Total pharyngolaryngectomy for squamous cell carcinoma of hypopharynx: a review. Laryngoscope 115:864–869
5. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102–114. doi:10.1038/nrg2290
6. Nelson KM, Weiss GJ (2008) MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 7:3655–3660. doi:10.1158/1535-7163
7. Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
8. −ΔΔCt) method. Methods 25(4):402–408
9. Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A (2010) Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Cancer Gene Ther 17:275–288
10. Fang J, Yu Z, Lian M, Ma H, Tai J, Zhang L, Han D (2012) Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. Mol Cell Biochem 360:301–307. doi:10.1007/s11010-011-1069-x
11. Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ (2014) MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol 20(46):17439–17447. doi:10.3748/wjg.v20.i46.17439
12. Thomas M, Lieberman J, Lal A (2010) Desperately seeking microRNA targets. Nat Struct Mol Biol 17:1169–1174
13. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
14. Cheng Q, Yi B, Wang A, Jiang X (2013) Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 6:1675–1684. doi:10.2147/OTT.S52730
15. Sethi N, Wright A, Wood H, Rabbitts P (2014) MicroRNAs and head and neck cancer: reviewing the first decade of research. Eur J Cancer 50(15):2619–2635. doi:10.1016/j.ejca.2014.07.012
16. Wang LG, Ni Y, Su BH, Mu XR, Shen HC, Du JJ (2013) MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int J Oncol 42(3):957–962. doi:10.3892/ijo.2013.1767
17. Yi R, Poy MN, Stoffel M, Fuchs E (2008) A skin microRNA promotes differentiation by repressing ‘stemness’. Nature 452:225–229
18. He JH, Li YM, Li YG, Xie XY, Wang L, Chun SY, Cheng WJ (2013) hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide. Exp Ther Med 5(5):1315–1321
19. Wang N, Liang H, Zhou Y, Wang C, Zhang S, Pan Y, Wang Y, Yan X, Zhang J, Zhang CY, Zen K, Li D, Chen X (2014) miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. PLoS One 9:e105570
20. Miao L, Xiong X, Lin Y, Cheng Y, Lu J, Zhang J, Cheng N (2014) miR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells. Oncol Lett 7(3):658–662
21. Zhang Z, Zhang B, Li W, Fu L, Fu L, Zhu Z, Dong JT (2011) Epigenetic silencing of miR-203 upregulates SNAI2 and contributes to the invasiveness of malignant breast cancer cells. Genes Cancer 2:782–791. doi:10.1177/1947601911429743
22. Zhang F, Yang Z, Cao M, Xu Y, Li J, Chen X, Gao Z, Xin J, Zhou S, Zhou Z, Yang Y, Sheng W, Zeng Y (2014) MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett 342:121–129. doi:10.1016/j
23. Wei W, Wanjun L, Hui S, Dongyue C, Xinjun Y, Jisheng Z (2013) miR-203 inhibits proliferation of HCC cells by targeting survivin. Cell Biochem Funct 31:82–85. doi:10.1002/cbf
24. Bian K, Fan J, Zhang X, Yang XW, Zhu HY, Wang L, Sun JY, Meng YL, Cui PC, Cheng SY, Zhang J, Zhao J, Yang AG, Zhang R (2012) MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett 586:804–809
25. Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Sakai H, Fujita H, Nakata K, Tanaka M (2010) MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol 17:3120–3128
26. Wang S, Zhao X, Wang J, Wen Y, Zhang L, Wang D, Chen H, Chen Q, Xiang W (2013) Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Med Oncol 30:681. doi:10.1007/s12032-013-0681-x
27. Kikkawa N, Hanazawa T, Fujimura L, Nohata N, Suzuki H, Chazono H, Sakurai D, Horiguchi S, Okamoto Y, Seki N (2010) miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer 103(6):877–884. doi:10.1038/sj.bjc.6605811
28. Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK, Wurz K, O’Briant KC, Godwin AK, Urban ND, Ruzzo WL, Gentleman R, Drescher CW, Swisher EM, Tewari M (2012) An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Res 40:499–510. doi:10.1093/nar/gkr731
29. Bailey SG, Sanchez-Elsner T, Stephanou A, Cragg MS, Townsend PA (2010) Regulating the genome surveillance system: miRNAs and the p53 super family. Apoptosis 15:541–552. doi:10.1007/s10495-010-0456-1
30. Ory B, Ellisen LW (2011) A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity. Oncotarget 2(3):259–264
31. Odar K, Bostjancic E, Gale N, Glavac D, Zidar N (2012) Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck. Histopathology 61(2):257–265. doi:10.1111/j.1365-2559.2012.04242.x
32. Wang Z, Wen L, Ma X, Chen Z, Yu Y, Zhu J, Wang Y, Liu Z, Liu H, Wu D, Zhou D, Li Y (2012) High expression of lactotriaosylceramide, a differentiation-associated glycosphingolipid, in the bone marrow of acute myeloid leukemia patients. Glycobiology 22:930–938. doi:10.1093/glycob/cws061
33. Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, Sasaki K, Narimatsu H (2001) Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem 276:22032–22040